Olanzapine increases allopregnanolone in the rat cerebral cortex

Biological Psychiatry

Volumn 47, Issue 11, 2000, Pages 1000-1004

  Marx, Christine E ^a,b   Duncan, Gary E ^a,b   Gilmore, John H ^a,b   Lieberman, Jeffrey A ^a   Morrow, A Leslie ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Allopregnanolone; GABA; Neurosteroid; Olanzapine; Schizophrenia

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOSTERONE; NEUROSTEROID; OLANZAPINE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; SCHIZOPHRENIA;

ANIMALS; BENZODIAZEPINES; CEREBRAL CORTEX; CORTICOSTERONE; GABA MODULATORS; MALE; PIRENZEPINE; PREGNANOLONE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 0034212307     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00305-4     Document Type: Article

References (39)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
2. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res. 24:1997;349-355.
3. Belelli D., Bolger M.B., Kelvin G.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol. 166:1989;325-329.
4. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and anterior cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
5. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 12:1992;924-929.
6. A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res. 755:1997;121-129.
7. Calogero A.E., Gallucci W.T., Chrousos G.P., Gold P.W. Interactions between GABAergic neurotransmission and rat corticotropin releasing hormone secretion in vitro Theoretical and clinical implications . Brain Res. 463:1988;28-36.
8. Carpenter W.T., Buchanan R.W., Kirkpatrick B., Breier A.F. Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry. 156:1999;299-303.
9. Corpechot C., Collins B.E., Carey M.P., Tsouros A., Robel P., Fry J.P. Brain neurosteroids during the mouse oestrous cycle. Brain Res. 766:1997;276-280.
10. Crawley J.N., Glowa J.R., Majewska M.D., Paul S.M. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398:1986;382-385.
11. Devaud L.L., Purdy R.H., Morrow A.L. The neurosteroid 3α-hydroxy-5α-pregnan-20-one protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res. 19:1995;350-355.
12. Finn D.A., Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther. 271:1994;164-170.
13. Genazzani A.R., Petragilia F., Bernardi F., Casarosa E., Salvestrone C., Tonetti A., et al. Circulating levels of allopregnanolone in humans Gender age, and endocrine influences . J Clin Endocrinol Metab. 83:1998;2099-2103.
14. Grobin A.C., Roth R.H., Deutch A.Y. Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3α,21-dihydroxy-5α-pregnane-20-one. Brain Res. 578:1992;351-356.
15. Guo A.L., Petraglia F., Criscuolo M., Ficarra G., Nappi R.E., Palumbo M.A., et al. Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol Endocrinol. 9:1995;1-7.
16. Inoue T., Tsuchiya K., Koyama T. Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear. Pharmacol Biochem Behav. 55:1996;195-201.
17. Janis G.C., Devaud L.L., Mitsuyama H., Morrow A.L. Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3α-hydroxy-5α-pregnan-20-one in male and female rats. Alcohol Clin Exp Res. 22:1998;2055-2061.
18. Khisti R.T., Mandhane S.N., Chopde C.T. The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces catalepsy in mice. Neurosci Lett. 251:1998;85-88.
19. Moore N.A., Rees G., Sanger G., Tye N.C. Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol. 5:1994;196-202.
20. Morrow A.L., Devaud L.L., Purdy R.H., Paul S.M. Neuroactive steroid modulators of the stress response. Ann N Y Acad Sci. 771:1995;257-272.
21. Morrow A.L., Pace J.R., Purdy R.H., Paul S.M. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels Evidence for multiple steroid recognition sites . Mol Pharmacol. 37:1990;263-270.
22. Morrow A.L., Suzdak P.D., Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol. 142:1987;483-485.
23. Motzo C., Porceddu M.L., Maira G., Flore G., Concas A., Dazzi L., Biggio G. Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J Psychopharmacol. 10:1996;266-272.
24. Nanry K.P., Pollard G.T., Howard J.L. Olanzapine moderately increases conflict responding but does not produce a benzodiazepine-like cue in rat. Drug Dev Res. 34:1995;317-319.
25. Patchev V.K., Hassan A.H.S., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology. 15:1996;533-540.
26. Patchev V.K., Shoaib M., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
27. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
28. Piazza P.V., Barrot M., Rouge-Pont F., Marinelli M., Maccari S., Abrous D.N., et al. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Natl Acad Sci U S A. 93:1996;15445-15450.
29. Pritchett D.B., Luddens H., Seeburg P.H. Type I and type II GABA-benzodiazepine receptors produced in transfected cells. Science. 245:1989;1389-1392.
30. A receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
31. A receptors. Neuron. 4:1990;759-765.
32. Purdy R.H., Moore P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., et al. Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids. 55:1990;290-296.
33. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of γ-aminobutyric acid typa A receptor active steroids in the rat brain. Proc Natl Acad Sci U S A. 88:1991;4553-4557.
34. Reynolds G.P., Beasley C.L. Deficits of parvalbumin-expressing neurons in the prefrontal cortex in schizophrenia. Schizophr Res. 36:1999;75.
35. Robel P., Baulieu E.E. Neurosteroids Biosynthesis and function . Crit Rev Neurobiol. 9:1995;383-394.
36. Van Kammen DP (1977): γ-Aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134:138-143; correction 134:463-464.
37. Van Kammen DP (1977): γ-Aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134:138-143; correction 134:463-464.
38. Wieland S., Lan N.C., Mirasedeghi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 565:1991;263-268.
39. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A. 95:1998;5341-5346.